MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma

Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway

Eek‐hoon Jho, Tong Zhang, Claire Domon–Dell et al. · Molecular and Cellular Biology · 2002 · 1.7K citations · Full text

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

Matthew P. Coghlan, Ainsley A. Culbert, Darren A.E. Cross et al. · Chemistry & Biology · 2000 · 888 citations · Full text

Biochemistry, Natural Sciences, Glycobiology +7

Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation

Ichiro Satokata, Liang Ma, Hayato Ohshima et al. · Nature Genetics · 2000 · 736 citations

Mice Causes, Developmental Biology, Sclerostin +11

Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer

Daniela M. Dinulescu, Tan A. Ince, Bradley J. Quade et al. · Nature Medicine · 2004 · 599 citations

Endometrioid Ovarian Cancer, Gynecology, Mouse Models +8

Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma

Kuan‐Ting Kuo, Tsui-Lien Mao, Siân Jones et al. · American Journal Of Pathology · 2009 · 462 citations · Full text

Oncogenic Agent, Medicine, Pathology +8